summit trial tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Tirzepatide for maintenance of bodyweight
Description
Zepbound is recommended for individuals with a Body Mass Index (BMI) of 27 or higher, especially those with obesity-related health conditions such as type 2 diabetes or hypertension
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
For how long can I use Mounjaro

Blood Pressure Medications : Semaglutide may help lower blood pressure in some patients, especially if they are also losing weight

The government of P.E.I

Tirzepatide (Mounjaro, Zepbound) Strengths: Highest efficacy for both glucose control and weight loss Dual mechanism (GLP-1 + GIP) may provide unique benefits Once-weekly dosing Generally well-tolerated Considerations: Higher cost than semaglutide Less long-term safety data (newer medication) Cardiovascular outcome trial not yet complete (though expected to be positive) Best for: Patients prioritizing maximum weight loss